SlideShare a Scribd company logo
A Novel Cardiac Pacing Paradigm for
 Atrial Fibrillation and Heart Failure
                Patients




        George Emanuel Yanulis, PhD
Outline

   Atrial Fibrillation (AF) and heart failure (HF)

   Coupled Pacing (CP) and sustained CP applied to
    persistent AF

   Cardiac conduction pathways

   Cardiac resynchronization therapy non-responders

   The CRT+CP pacing paradigm

   Simulation Studies (Great Cardiac Vein)

   Conclusions
Atrial Fibrillation

   At age 40, remaining lifetime risks for AF were 26.0%
    for men and 23.0% for women.


   From 1996 to 2001, hospitalizations with AF as the
    first-listed diagnosis increased 34%.


   AF is an independent risk factor for ischemic stroke,
    increasing risk about 4 to 5 fold.




               Heart Disease and Stroke Statistics—2007 Update
Clinical Correlates of AF


   Overall 752 patients from the ALPHA Registry,
    corresponding to a prevalence of 21.4% (95% CI
    20.0%–22.8%) were in AF.

   The total proportion of HF patients with atrial
    fibrillation at any time is approximately 41% .

   AF is more prevalent among HF patients with
    relatively preserved systolic function.




            European Journal of Heart. Volume 9, Issue 5, May 2007
Heart Failure
   It has been estimated that 4.6 million persons have
    heart failure (HF).

   An estimated 400,000 to 700,000 new cases develop
    each year.

   U.S. Hospital discharges for HF rose from 399,000 in
    1979 to 1,099,000 in 2004, an increase of 175%
    (National Hospital Discharge Survey).

   HF is the primary diagnosis for 875,000
    hospitalizations annually, and it is the most common
    diagnosis among hospitalized patients 65 years of
    age or older.



                     AHA 2007 Statistics Update
Anatomical/Physiological Considerations

   Similar anatomical and physiological characteristics
    between the canine and human cardiovascular
    systems.

   The canine model is a well-established model for
    studying AF and chronic heart failure (CHF).

   And the ability to monitor canines in the conscious
    state.
1 Pacing Paradigm
               st

   Coupled Pacing (CP)-rate control.

   CP is designed to improve cardiac function during
    atrial fibrillation (AF) and heart failure.

   This pacing therapy both slows the rate of
    ventricular contraction and increases contractility.

   CP first senses the intrinsic electrical activation of
    the heart. Then a delayed stimulation coupled to this
    intrinsic activation is applied, resulting in a second
    electrical activation with minimal mechanical
    contraction.
Schematic Representation of Cardiac
Conduction Pathways in the Human Heart




              http://images.main.uab.edu/
Concept of Coupled Pacing during AF
   (Electrically Activating the Ventricles after a Specific Delay)


Atrium
AVN

Ventricle

             ♥ ♥ ♥ ♥ ♥♥ ♥ ♥ ♥ ♥ ♥♥ ♥
                                  ♥
Atrium
AVN

Ventricle
             ♥ ♥♥ ♥                     ♥♥ ♥♥
AF can Lead to Ventricular Tachycardia

   The AV node is not a perfect filter.

   During AF, rapid irregular ventricular contractions
    can occur.

   These ventricular contractions fail to eject blood

   CP blocks approximately one-half of the ventricular
    activations leading to slower, stronger
    contractions
Coupled Pacing vs. Paired Stimulation
Prior Coupled Pacing Studies
   Coupled pacing (CP) acutely does result in a
    sustained increase in myocardial contractility.

   CP is different from paired stimulation                  in that it
    senses the intrinsic activation and then                 paces the
    heart.

   And CP increases the mechanical efficiency during
    acute AF and has a positive inotropic effect on the
    heart.

           Yamada H et al. Am J Physiol 287: H2016-H2022, 2004.
My Studies on Chronic Coupled Pacing

   AF is a prevalent cardiac arrhythmia.

   Are the effects of persistent coupled pacing (CP)
    beneficial?

   Can the effects of chronic effects of CP be
    sustained?
Placement of the Leads, Adapters, and
    Pacemakers for the AF Model




    Cingoz et al (2007). The Annals of Thoracic Surgery, 83(5), 1858-1862.
Effects of Chronic AF

   Significant tachycardia-mediated left ventricular (LV)
    remodeling, resulting in both left atrial and left
    ventricular dilatation.

   The left ventricular end diastolic volume (LVEDV)
    increased from 62.3 ± 4.78 mL to 75.5 ± 6.65 mL (BL
    vs. AF, p<0.01).

   And the left ventricular end systolic volume (LVESV)
    increased from 30.7 ± 2.57 mL to 51 ± 4.57 mL
    (p<0.001).




         Yanulis et al (2008). The Annals of Thoracic Surgery, 86(3), 984-987
ECG Tracings
                              SINUS
            1             2                 3              4




     0                            1                            2




          1
                                  AF
                              3         4        5
                  2




     0                            1                            2




                                  CP
                              2                           4
                 1                      3




     0                            1                            2




The top panel shows when the animal was in sinus         rhythm. The
number indicates the intrinsic electrical activations.    The middle
panel show when the animal was in persistent AF.          The bottom
panel shows coupled pacing.
Effects of Chronic AF and CP on Cardiac Function
            60                                               200


            50                     *                         175
                                                     #
                                                             150
            40




                                                                   VRMC (C/min)
                                                             125
 LVEF (%)




                                   *                #
            30                                               100

                                                             75
            20
                                                             50
            10
                                                             25

            0                                                0
                 Sinus      Chronic AF      Coupled Pacing
                   0             6-8             10-12

                            Time in weeks




Yanulis et al (2008). The Annals of Thoracic Surgery, 86(3), 984-987
Results of Sustained CP on LV Volumes-
         Reversed Remodeling

Effects of Chronic AF and CP on Cardiac Volumes
                                                                         The LVEDV decreased
                                                                          from 75.5 ± 6.65 mL to
                                                                          65 ± 3.22 mL (AF vs.
                100
                                                              LVEDV
                                                              LVESV
                 80            *                              LAV         CP, p<0.0.5) .
                                                  #
                 60
                                   *
 Volumes (ml)




                                                                         The LVESV decreased
                                         *
                                                                          from 51 ± 4.57 mL to
                 40
                                                         #

                 20                                                       34.5    ±  2.41  mL
                  0
                                                                          (p=0.001).
                      Sinus   Chronic AF       Coupled Pacing
                       0           6-8                10-12

                               Time in weeks




                        Yanulis et al (2008). The Annals of Thoracic Surgery, 86(3), 984-987
Hemodynamic Tracings

    ECG


RV electrogram

     dp/dt
   (mmHg/s)


 LV Pressure
   (mmHg)


 Aortic Flow
   (L/min)




                    Coupled Pacing                     Coupled Pacing
                         OFF                                ON

 Marks above the left ventricular (LV) pressure tracings illustrate VRMC, and
 marks above the aortic flow tracings illustrate VREJ.
My studies on Chronic Coupled Pacing

   Are the effects of persistent coupled pacing (CP)
    beneficial?

       Answer: Yes.

   Can the effects of CP be sustained?

       Answer: Yes.
The 2nd Pacing Paradigm (CRT+CP Pacing)

   Rather than CRT ending during episodes of AF, this
    new pacing regimen (CRT+CP) could be applied
    desynchronized HF and AF patients.

   Briefly, CRT+CP, involves:

       The application of a 1st stimuli to the left ventricle and a 2nd
        stimuli to the right ventricle simultaneously in the same
        manner as CRT is used clinically today

       Thus, these first 2 stimulations will result in a more
        synchronized electrical activation and subsequent
        contraction of both ventricles

       And then a 3rd premature paced beat is applied to activate
        both ventricles electrically but not mechanically for CP.
Atrial Fibrillation (AF) in Heart Failure
                  (HF) Patients

   AF and HF frequently coexist.
   HF promotes AF.
   And AF may cause or aggrevate HF.
   25% of HF patients also have AF
   34% of HF patients have LBBB.
   30% of above these patients also have AF.




               Eur Heart J. 2002 Nov; 23(21): 1692-8.
Electrical Activations of the Normal Heart




                 www.physiome.org
RV Apex Pacing          Left Bundle Branch Block




                 Prinzen et al, 2000
Clinical Significance of CRT

   CRT has been established as an effective pacing
    therapy in most heart failure patients with left bundle
    branch block.


   Heart failure patients with drug-refractory atrial
    fibrillation may require ablation therapy to benefit
    from CRT.
Current Pacing Therapies
                                              Biventricular Pacing
                                               (CRT) consists of:

                                                  A pacemaker
                                                   generator (#1)

                                                  A right atrial pacing
                                                   wire (#2)

                                                  A right ventricular
                                                   pacer wire (#3)

                                                  And a coronary sinus
                                                   (LV) pacing wire (#4).




Circulation. 2005 Sep 27;112(13):e236-7.
AF in HF Patients with Left Bundle
            Branch Block (LBBB)
   Cardiac resynchronization therapy (CRT) is effective
    in many HF w/ LBBB.

   CRT is not effective in some HF patients despite
    resynchronization (non-responders) even during
    sinus rhythm.

   CRT can only be effective if the ventricular rate is
    controlled during AF.

   CP added to CRT could be an effective means of rate
    control.
The CRT+CP Pacing Paradigm

   Our research to date has demonstrated that the
    addition of a coupled paced beat significantly
    increased:

       The left ventricular ejection fraction (LVEF)

       And the left ventricular strain as well

   This pacing paradigm may improve overall
    myocardial performance in HF and AF patients.
Animal preparation

            RA electrode


                                   LV electrode


Vagal electrode


 RV electrode




                                Epicardial Echocardiography
Experimental protocol
Sinus
                               Right atrium        Left ventricle
Rhythm         Baseline             VS
               N=6               Right ventricle
     Step 1
Atrial
Fibrillation   Atrial pacing
               N=6


               RV pacing
     Step 2
               N=6



     Step 3    CRT
               N=6



               CRT+ CP
    Step 4     N=6               CRT      CP
                                              RR




               CRT-VS
     Step 5    N=3                       VS
Sinus rhythm                     Atrial Fibrillation
  Baseline      RV pacing      CRT            CRT-VS       CRT+CP
 HR=103bpm     HR=178bpm    HR=197bpm        HR=110bpm    HR=110bpm


   Step 1        Step 2       Step 3           Step 5       Step 4




 QRS=80ms      QRS=120ms    QRS=90ms         QRS=90ms     QRS=90ms
  SD=5%         SD=16%       SD=5%            SD=3%        SD=5%

                                                   -12%
      -14%        -7%           -3%                         -19%

Dog #176
Use of CRT+CP on CRT Non-responders

   CRT+CP may convert non-responders to responders
    in HF patients in sinus rhythm.

   The addition of CP to CRT permits effective CRT to
    continue when AF and the subsequent rapid
    ventricular contractions occurs via its effective rate
    control mechanism.
Sensors to Control Pacing

   Presently measuring single site pressure, thoracic
    impedance, and the rate of cardiac electrical
    activation but not the rate of flow are used as
    sensors to control cardiac pacemakers.

   Which parameter is best to use to control pacing?
Simulation of Flow in the Great Cardiac Vein

    I developed mock coronary venous circulatory
     circuits which tested whether the differential
     pressure obtained in this system is representative of
     flow.

    DATAQ® software was used to acquire the raw data
     obtained from my mechanical models.

    Then Origin® software was used to plot the
     relationship between differential pressure and flow.
Pressure Recording (Millar Sensors)


                                                        Trial #3-performed on 8-20-07
                                          110
                                          100
                                          90
                                          80




                            Flow (ml/m)
                                          70
                                          60
                                          50
                                          40
                                          30

                                            0.0   0.1     0.2   0.3   0.4   0.5   0.6   0.7   0.8
                                                         Change in Pressure (mmHg)




Photograph of the Mock II     Mock II Circulatory Circuit
   Circulatory Circuit                 (Results)
Conclusions of My Simulation Studies

   My simulation results demonstrated that flow could
    be represented by measuring differential pressure.

   As flow is increased in the great cardiac vein, the
    differential pressure (GCV1 – GCV2) would change
    the balance of a Wheatstone bridge circuit
    configuration, a low energy monitor.

   This with this flow measurement and other cardiac
    measurements, optimizing the pacing paradigms
    such as CRT and or our novel pacing paradigm
    (CRT+CP) could be achieved.
Acknowledgements

   Don Wallick, Ph.D.
   Nolan Holland, Ph.D.
   George Chatzimavroudis, Ph.D.
   Christine Moravec, Ph.D.
   Walid Saliba, M.D.
   Brian Davis, Ph.D.
   Pascal Lim, M.D.
   Becky Laird
   Darlene Montgomery
   Shari Demarco, RVT
   Dana Frank, B.S.

More Related Content

Similar to PPT For Cardiac Pacing Research

Cardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure PatientsCardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure PatientsGeorge Yanulis
 
Low flow Low gradient severe aortic stenosis
Low flow Low gradient severe aortic stenosisLow flow Low gradient severe aortic stenosis
Low flow Low gradient severe aortic stenosis
Anuj Mehta
 
Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...
Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...
Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...
Brussels Heart Center
 
C Pdemo
C PdemoC Pdemo
C Pdemo
DonWallick
 
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Arrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced CardiomyopathiesArrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced Cardiomyopathies
magdy elmasry
 
2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...
2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...
2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...
Centro Diagnostico Nardi
 
Preeclampsia is a Heart Disease
Preeclampsia is a Heart DiseasePreeclampsia is a Heart Disease
Preeclampsia is a Heart Disease
Uscom - Presentations
 
Bohomolets septic shock
Bohomolets septic shockBohomolets septic shock
Bohomolets septic shockDr. Rubz
 
Aortic Valve Stenosis with low EF : TAVR versus Replacement
Aortic Valve Stenosis with low EF : TAVR versus ReplacementAortic Valve Stenosis with low EF : TAVR versus Replacement
Aortic Valve Stenosis with low EF : TAVR versus Replacement
drucsamal
 
2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...
2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...
2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...
Centro Diagnostico Nardi
 
Low flow Aortic Stenosis-latest explanations
Low flow Aortic Stenosis-latest explanationsLow flow Aortic Stenosis-latest explanations
Low flow Aortic Stenosis-latest explanations
Deep Chandh
 
Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...
Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...
Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...
Brussels Heart Center
 
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Chaichuk Sergiy
 
Year in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiographyYear in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiography
Praveen Nagula
 
Cirugía de la fibrilacion aislada por vía quirurgica
Cirugía de la fibrilacion aislada por vía quirurgicaCirugía de la fibrilacion aislada por vía quirurgica
Cirugía de la fibrilacion aislada por vía quirurgica
Clínica Universidad de Navarra
 

Similar to PPT For Cardiac Pacing Research (20)

Cardiac Pacing MS PPT
Cardiac Pacing MS PPTCardiac Pacing MS PPT
Cardiac Pacing MS PPT
 
Cardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure PatientsCardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure Patients
 
PPT for cardiac pacing
PPT for cardiac pacingPPT for cardiac pacing
PPT for cardiac pacing
 
Low flow Low gradient severe aortic stenosis
Low flow Low gradient severe aortic stenosisLow flow Low gradient severe aortic stenosis
Low flow Low gradient severe aortic stenosis
 
Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...
Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...
Impact de l’ablation IVP sur la décompensation cardiaque et le risque d’AVC. ...
 
C Pdemo
C PdemoC Pdemo
C Pdemo
 
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
 
Arrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced CardiomyopathiesArrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced Cardiomyopathies
 
2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...
2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...
2006 orvieto, giornate cardoilogiche orvietane. il trattamento non farmacolog...
 
Medical Sample 23
Medical  Sample 23Medical  Sample 23
Medical Sample 23
 
Preeclampsia is a Heart Disease
Preeclampsia is a Heart DiseasePreeclampsia is a Heart Disease
Preeclampsia is a Heart Disease
 
Tavi
TaviTavi
Tavi
 
Bohomolets septic shock
Bohomolets septic shockBohomolets septic shock
Bohomolets septic shock
 
Aortic Valve Stenosis with low EF : TAVR versus Replacement
Aortic Valve Stenosis with low EF : TAVR versus ReplacementAortic Valve Stenosis with low EF : TAVR versus Replacement
Aortic Valve Stenosis with low EF : TAVR versus Replacement
 
2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...
2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...
2009 acerra, congresso regionale sicoa, la terapia elettrica dello scompenso ...
 
Low flow Aortic Stenosis-latest explanations
Low flow Aortic Stenosis-latest explanationsLow flow Aortic Stenosis-latest explanations
Low flow Aortic Stenosis-latest explanations
 
Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...
Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...
Ablation ou traitement pharmacologique pour la FA : quelles stratégie à suivr...
 
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
Current Guidelines of Myocardial Revascularisation Patients with Stable Angin...
 
Year in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiographyYear in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiography
 
Cirugía de la fibrilacion aislada por vía quirurgica
Cirugía de la fibrilacion aislada por vía quirurgicaCirugía de la fibrilacion aislada por vía quirurgica
Cirugía de la fibrilacion aislada por vía quirurgica
 

PPT For Cardiac Pacing Research

  • 1. A Novel Cardiac Pacing Paradigm for Atrial Fibrillation and Heart Failure Patients George Emanuel Yanulis, PhD
  • 2. Outline  Atrial Fibrillation (AF) and heart failure (HF)  Coupled Pacing (CP) and sustained CP applied to persistent AF  Cardiac conduction pathways  Cardiac resynchronization therapy non-responders  The CRT+CP pacing paradigm  Simulation Studies (Great Cardiac Vein)  Conclusions
  • 3. Atrial Fibrillation  At age 40, remaining lifetime risks for AF were 26.0% for men and 23.0% for women.  From 1996 to 2001, hospitalizations with AF as the first-listed diagnosis increased 34%.  AF is an independent risk factor for ischemic stroke, increasing risk about 4 to 5 fold. Heart Disease and Stroke Statistics—2007 Update
  • 4. Clinical Correlates of AF  Overall 752 patients from the ALPHA Registry, corresponding to a prevalence of 21.4% (95% CI 20.0%–22.8%) were in AF.  The total proportion of HF patients with atrial fibrillation at any time is approximately 41% .  AF is more prevalent among HF patients with relatively preserved systolic function. European Journal of Heart. Volume 9, Issue 5, May 2007
  • 5. Heart Failure  It has been estimated that 4.6 million persons have heart failure (HF).  An estimated 400,000 to 700,000 new cases develop each year.  U.S. Hospital discharges for HF rose from 399,000 in 1979 to 1,099,000 in 2004, an increase of 175% (National Hospital Discharge Survey).  HF is the primary diagnosis for 875,000 hospitalizations annually, and it is the most common diagnosis among hospitalized patients 65 years of age or older. AHA 2007 Statistics Update
  • 6. Anatomical/Physiological Considerations  Similar anatomical and physiological characteristics between the canine and human cardiovascular systems.  The canine model is a well-established model for studying AF and chronic heart failure (CHF).  And the ability to monitor canines in the conscious state.
  • 7. 1 Pacing Paradigm st  Coupled Pacing (CP)-rate control.  CP is designed to improve cardiac function during atrial fibrillation (AF) and heart failure.  This pacing therapy both slows the rate of ventricular contraction and increases contractility.  CP first senses the intrinsic electrical activation of the heart. Then a delayed stimulation coupled to this intrinsic activation is applied, resulting in a second electrical activation with minimal mechanical contraction.
  • 8. Schematic Representation of Cardiac Conduction Pathways in the Human Heart http://images.main.uab.edu/
  • 9. Concept of Coupled Pacing during AF (Electrically Activating the Ventricles after a Specific Delay) Atrium AVN Ventricle ♥ ♥ ♥ ♥ ♥♥ ♥ ♥ ♥ ♥ ♥♥ ♥ ♥ Atrium AVN Ventricle ♥ ♥♥ ♥ ♥♥ ♥♥
  • 10. AF can Lead to Ventricular Tachycardia  The AV node is not a perfect filter.  During AF, rapid irregular ventricular contractions can occur.  These ventricular contractions fail to eject blood  CP blocks approximately one-half of the ventricular activations leading to slower, stronger contractions
  • 11. Coupled Pacing vs. Paired Stimulation
  • 12. Prior Coupled Pacing Studies  Coupled pacing (CP) acutely does result in a sustained increase in myocardial contractility.  CP is different from paired stimulation in that it senses the intrinsic activation and then paces the heart.  And CP increases the mechanical efficiency during acute AF and has a positive inotropic effect on the heart. Yamada H et al. Am J Physiol 287: H2016-H2022, 2004.
  • 13. My Studies on Chronic Coupled Pacing  AF is a prevalent cardiac arrhythmia.  Are the effects of persistent coupled pacing (CP) beneficial?  Can the effects of chronic effects of CP be sustained?
  • 14. Placement of the Leads, Adapters, and Pacemakers for the AF Model Cingoz et al (2007). The Annals of Thoracic Surgery, 83(5), 1858-1862.
  • 15. Effects of Chronic AF  Significant tachycardia-mediated left ventricular (LV) remodeling, resulting in both left atrial and left ventricular dilatation.  The left ventricular end diastolic volume (LVEDV) increased from 62.3 ± 4.78 mL to 75.5 ± 6.65 mL (BL vs. AF, p<0.01).  And the left ventricular end systolic volume (LVESV) increased from 30.7 ± 2.57 mL to 51 ± 4.57 mL (p<0.001). Yanulis et al (2008). The Annals of Thoracic Surgery, 86(3), 984-987
  • 16. ECG Tracings SINUS 1 2 3 4 0 1 2 1 AF 3 4 5 2 0 1 2 CP 2 4 1 3 0 1 2 The top panel shows when the animal was in sinus rhythm. The number indicates the intrinsic electrical activations. The middle panel show when the animal was in persistent AF. The bottom panel shows coupled pacing.
  • 17. Effects of Chronic AF and CP on Cardiac Function 60 200 50 * 175 # 150 40 VRMC (C/min) 125 LVEF (%) * # 30 100 75 20 50 10 25 0 0 Sinus Chronic AF Coupled Pacing 0 6-8 10-12 Time in weeks Yanulis et al (2008). The Annals of Thoracic Surgery, 86(3), 984-987
  • 18. Results of Sustained CP on LV Volumes- Reversed Remodeling Effects of Chronic AF and CP on Cardiac Volumes  The LVEDV decreased from 75.5 ± 6.65 mL to 65 ± 3.22 mL (AF vs. 100 LVEDV LVESV 80 * LAV CP, p<0.0.5) . # 60 * Volumes (ml)  The LVESV decreased * from 51 ± 4.57 mL to 40 # 20 34.5 ± 2.41 mL 0 (p=0.001). Sinus Chronic AF Coupled Pacing 0 6-8 10-12 Time in weeks Yanulis et al (2008). The Annals of Thoracic Surgery, 86(3), 984-987
  • 19. Hemodynamic Tracings ECG RV electrogram dp/dt (mmHg/s) LV Pressure (mmHg) Aortic Flow (L/min) Coupled Pacing Coupled Pacing OFF ON Marks above the left ventricular (LV) pressure tracings illustrate VRMC, and marks above the aortic flow tracings illustrate VREJ.
  • 20. My studies on Chronic Coupled Pacing  Are the effects of persistent coupled pacing (CP) beneficial?  Answer: Yes.  Can the effects of CP be sustained?  Answer: Yes.
  • 21. The 2nd Pacing Paradigm (CRT+CP Pacing)  Rather than CRT ending during episodes of AF, this new pacing regimen (CRT+CP) could be applied desynchronized HF and AF patients.  Briefly, CRT+CP, involves:  The application of a 1st stimuli to the left ventricle and a 2nd stimuli to the right ventricle simultaneously in the same manner as CRT is used clinically today  Thus, these first 2 stimulations will result in a more synchronized electrical activation and subsequent contraction of both ventricles  And then a 3rd premature paced beat is applied to activate both ventricles electrically but not mechanically for CP.
  • 22. Atrial Fibrillation (AF) in Heart Failure (HF) Patients  AF and HF frequently coexist.  HF promotes AF.  And AF may cause or aggrevate HF.  25% of HF patients also have AF  34% of HF patients have LBBB.  30% of above these patients also have AF. Eur Heart J. 2002 Nov; 23(21): 1692-8.
  • 23. Electrical Activations of the Normal Heart www.physiome.org
  • 24. RV Apex Pacing Left Bundle Branch Block Prinzen et al, 2000
  • 25. Clinical Significance of CRT  CRT has been established as an effective pacing therapy in most heart failure patients with left bundle branch block.  Heart failure patients with drug-refractory atrial fibrillation may require ablation therapy to benefit from CRT.
  • 26. Current Pacing Therapies  Biventricular Pacing (CRT) consists of:  A pacemaker generator (#1)  A right atrial pacing wire (#2)  A right ventricular pacer wire (#3)  And a coronary sinus (LV) pacing wire (#4). Circulation. 2005 Sep 27;112(13):e236-7.
  • 27. AF in HF Patients with Left Bundle Branch Block (LBBB)  Cardiac resynchronization therapy (CRT) is effective in many HF w/ LBBB.  CRT is not effective in some HF patients despite resynchronization (non-responders) even during sinus rhythm.  CRT can only be effective if the ventricular rate is controlled during AF.  CP added to CRT could be an effective means of rate control.
  • 28. The CRT+CP Pacing Paradigm  Our research to date has demonstrated that the addition of a coupled paced beat significantly increased:  The left ventricular ejection fraction (LVEF)  And the left ventricular strain as well  This pacing paradigm may improve overall myocardial performance in HF and AF patients.
  • 29. Animal preparation RA electrode LV electrode Vagal electrode RV electrode Epicardial Echocardiography
  • 30. Experimental protocol Sinus Right atrium Left ventricle Rhythm Baseline VS N=6 Right ventricle Step 1 Atrial Fibrillation Atrial pacing N=6 RV pacing Step 2 N=6 Step 3 CRT N=6 CRT+ CP Step 4 N=6 CRT CP RR CRT-VS Step 5 N=3 VS
  • 31. Sinus rhythm Atrial Fibrillation Baseline RV pacing CRT CRT-VS CRT+CP HR=103bpm HR=178bpm HR=197bpm HR=110bpm HR=110bpm Step 1 Step 2 Step 3 Step 5 Step 4 QRS=80ms QRS=120ms QRS=90ms QRS=90ms QRS=90ms SD=5% SD=16% SD=5% SD=3% SD=5% -12% -14% -7% -3% -19% Dog #176
  • 32. Use of CRT+CP on CRT Non-responders  CRT+CP may convert non-responders to responders in HF patients in sinus rhythm.  The addition of CP to CRT permits effective CRT to continue when AF and the subsequent rapid ventricular contractions occurs via its effective rate control mechanism.
  • 33. Sensors to Control Pacing  Presently measuring single site pressure, thoracic impedance, and the rate of cardiac electrical activation but not the rate of flow are used as sensors to control cardiac pacemakers.  Which parameter is best to use to control pacing?
  • 34. Simulation of Flow in the Great Cardiac Vein  I developed mock coronary venous circulatory circuits which tested whether the differential pressure obtained in this system is representative of flow.  DATAQ® software was used to acquire the raw data obtained from my mechanical models.  Then Origin® software was used to plot the relationship between differential pressure and flow.
  • 35. Pressure Recording (Millar Sensors) Trial #3-performed on 8-20-07 110 100 90 80 Flow (ml/m) 70 60 50 40 30 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 Change in Pressure (mmHg) Photograph of the Mock II Mock II Circulatory Circuit Circulatory Circuit (Results)
  • 36. Conclusions of My Simulation Studies  My simulation results demonstrated that flow could be represented by measuring differential pressure.  As flow is increased in the great cardiac vein, the differential pressure (GCV1 – GCV2) would change the balance of a Wheatstone bridge circuit configuration, a low energy monitor.  This with this flow measurement and other cardiac measurements, optimizing the pacing paradigms such as CRT and or our novel pacing paradigm (CRT+CP) could be achieved.
  • 37. Acknowledgements  Don Wallick, Ph.D.  Nolan Holland, Ph.D.  George Chatzimavroudis, Ph.D.  Christine Moravec, Ph.D.  Walid Saliba, M.D.  Brian Davis, Ph.D.  Pascal Lim, M.D.  Becky Laird  Darlene Montgomery  Shari Demarco, RVT  Dana Frank, B.S.

Editor's Notes

  1. This schema shows the concept of bigeminal pacing. 1